Abstract
Tong SY, Lye DC, Yahav D, et al. Effect of vancomycin or daptomycin with vs without an antistaphylococcal β-lactam on mortality, bacteremia, relapse, or treatment failure in patients with MRSA bacteremia: a randomized clinical trial. JAMA. 2020;323:527-37. 32044943.
MeSH terms
-
Anti-Bacterial Agents / therapeutic use
-
Bacteremia* / drug therapy
-
Daptomycin* / therapeutic use
-
Humans
-
Methicillin-Resistant Staphylococcus aureus*
-
Recurrence
-
Staphylococcal Infections* / drug therapy
-
Treatment Failure
-
Treatment Outcome
-
Vancomycin / therapeutic use
-
beta-Lactams / therapeutic use
Substances
-
Anti-Bacterial Agents
-
beta-Lactams
-
Vancomycin
-
Daptomycin